ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Comorbidities associated with bronchiectasis

Comorbidities associated with bronchiectasis
Comorbidities seen in children and adults
Malnutrition Children with bronchiectasis are threefold more likely to have a history of malnutrition before diagnosis of bronchiectasis[1]. Up to three-quarters of indigenous children with bronchiectasis have poor weight gain[2]. High body mass index is associated with improved survival in adults with bronchiectasis[3,4].
Vitamin D deficiency Vitamin D deficiency is associated with increased risk for respiratory infections and more severe bronchiectasis[5-7].
Hemoptysis Up to 10% of children presenting to tertiary hospitals with hemoptysis have underlying bronchiectasis[8]. Hemoptysis is a marker for advanced lung disease and can be life-threatening.
Osteopenia Osteopenia is more common in children with bronchiectasis compared with controls; the risk of osteoporosis and osteopenia increases with age[9].
Asthma-like symptoms Asthma can coexist with bronchiectasis and is a poor prognostic factor[2,10-12]. In some cases, bronchiectasis is wrongly labeled as asthma before a diagnosis is made.
Sleep disturbance Patients with bronchiectasis, particularly those with nocturnal symptoms, often have disturbed sleep and poor sleep quality. The risk increases with disease severity[13].
Hypoxemia/pulmonary hypertension Patients with longstanding and severe bronchiectasis may develop pulmonary hypertension and hypoxemia[14]. This is caused by destruction of the pulmonary vascular bed and chronic hypoxia.
Poor dental health A possible link has been suggested between oral health and pulmonary disease, including bronchiectasis. The proposed mechanism is that oral disease pathogens are aspirated into the lung, where they contribute to the pulmonary disease[15,16]. There are no data on dental or oral hygiene in children with bronchiectasis.
GERD GERD symptoms are common in adults and children with bronchiectasis[10,17,18]. GERD is thought to be a contributor to the disease process, but benefits of treating GERD have not been proven. Furthermore, treatment of GERD by gastric acid suppression is associated with other adverse events including increased risk for respiratory infections (although this may be due to confounding rather than a causal effect)[19].
Reduced exercise capacity Children with bronchiectasis have reduced exercise capacity, physical activity, and fundamental movement skills[20-23].
Comorbidities reported in adults but not in children
Broncholithiasis Broncholithiasis (bronchial stones) has been described in several adult patients with localized bronchiectasis[24].
Cardiac morbidity In adult patients with bronchiectasis, cardiac findings may include higher pulmonary artery pressure, lower myocardial performance index, and right and left ventricular systolic dysfunction[25,26]. In a study in children, ventricular systolic functions were preserved, but some had changes in left ventricular diastolic function[27].
Hypertrophic osteoarthropathy Hypertropic osteoarthropathy is characterized by periostosis of the tubular bones, arthritis-like features, and digital clubbing. It is an established association with bronchiectasis in patients with cystic fibrosis[28] and has also been described in case reports of adults and children with bronchiectasis unrelated to cystic fibrosis[29,30].
Systemic amyloidosis Bronchiectasis has been reported as 1 of the causes of amyloidosis in case series of amyloidosis[31,32]. Amyloidosis is also a rare complication of cystic fibrosis[33].
Lung cancer or any cancer Epidemiologic data from Taiwan, based on more than 50,000 patients[34,35].
GERD: gastroesophageal reflux disease.
References:
  1. Valery PC, Torzillo PJ, Mulholland K, et al. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 2004; 23:902.
  2. Chang AB, Masel JP, Boyce NC, et al. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol 2003; 35:477.
  3. Lee JM, Lee SA, Han CH, et al. Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study. Respir Med 2021; 180:106370.
  4. Onen ZP, Gulbay BE, Sen E, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med 2007; 101:1390.
  5. Binks MJ, Smith-Vaughan HC, Marsh R, et al. Cord blood vitamin D and the risk of acute lower respiratory infection in Indigenous infants in the Northern Territory. Med J Aust 2016; 204:238.
  6. Niksarlıoğlu EY, Kılıç L, Bilici D, et al. Vitamin D Deficiency and Radiological Findings in Adult Non-Cystic Fibrosis Bronchiectasis. Turk Thorac J 2020; 21:87.
  7. Ferri S, Crimi C, Heffler E, et al. Vitamin D and disease severity in bronchiectasis. Respir Med 2019; 148:1.
  8. Moynihan KM, Ge S, Sleeper LA, et al. Life-Threatening Hemoptysis in a Pediatric Referral Center. Crit Care Med 2021; 49:e291.
  9. Guran T, Turan S, Karadag B, et al. Bone mineral density in children with non-cystic fibrosis bronchiectasis. Respiration 2008; 75:432.
  10. Banjar HH. Clinical profile of Saudi children with bronchiectasis. Indian J Pediatr 2007; 74:149.
  11. Kang HR, Choi GS, Park SJ, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis (Seoul) 2014; 77:209.
  12. Donnelly D, Critchlow A, Everard ML. Outcomes in children treated for presistent bacterial bronchitis. Thorax 2007; 62:80.
  13. Erdem E, Ersu R, Karadag B, et al. Effect of night symptoms and disease severity on subjective sleep quality in children with non-cystic-fibrosis bronchiectasis. Pediatr Pulmonol 2011; 46:919.
  14. Devaraj A, Wells AU, Meister MG, et al. Pulmonary Hypertension in Patients With Bronchiectasis: Prognostic Significance of CT Signs. Am J Roentgenol 2011; 196:1300.
  15. Manger D, Walshaw M, Fitzgerald R, et al. Evidence summary: the relationship between oral health and pulmonary disease. Br Dent J 2017; 222:527.
  16. Pu CY, Seshadri M, Manuballa S, Yendamuri S. The Oral Microbiome and Lung Diseases. Current Oral Health Reports 2020; 7:79.
  17. McDonnell MJ, O'Toole D, Ward C, et al. A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk. Respir Med 2018; 141:132.
  18. Karadag B, Karakoc F, Ersu R, et al. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005; 72:233.
  19. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301:2120.
  20. Edwards EA, Narang I, Li A, et al. HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis. Eur Respir J 2004; 24:538.
  21. Swaminathan S, Kuppurao KV, Somu N, Vijayan VK. Reduced exercise capacity in non-cystic fibrosis bronchiectasis. Indian J Pediatr 2003; 70:553.
  22. Joschtel B, Gomersall SR, Tweedy S, et al. Objectively measured physical activity and sedentary behaviour in children with bronchiectasis: a cross-sectional study. BMC Pulm Med 2019; 19:7.
  23. Joschtel B, Gomersall SR, Tweedy S, et al. Fundamental movement skill proficiency and objectively measured physical activity in children with bronchiectasis: a cross-sectional study. BMC Pulm Med 2021; 21:269.
  24. Kamble MA, Thawait AP, Kamble AT. Rare presentation of bronchiectasis with multiple bronchial stones. Scott Med J 2015; 60:e14.
  25. Alzeer AH, Al-Mobeirek AF, Al-Otair HA, et al. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest 2008; 133:468.
  26. Zeinaloo AA, Aghamohammadi A, Shabanian R, et al. Echocardiographic abnormalities and their correlation with bronchiectasis score in primary antibody deficiencies. J Cardiovasc Med (Hagerstown) 2010; 11:244.
  27. AkalIn F, Köroglŭ TF, Bakaç S, Dagli E. Effects of childhood bronchiectasis on cardiac functions. Pediatr Int 2003; 45:169.
  28. Clarke E, Bright-Thomas R. Hypertrophic Osteoarthropathy in Cystic Fibrosis. Arthritis Rheumatol 2019; 71:1633.
  29. Tekiteki A, Good WR, Diggins B, et al. Recurrent hypertrophic pulmonary osteoarthropathy in an adult with bronchiectasis. Respirol Case Rep 2020; 8:e00602.
  30. Ozcay F, Ozbek N, Saatci U. Relapsing hypertrophic osteoarthropathy in a child with bronchiectasis. Indian Pediatr 2002; 39:1152.
  31. Tuglular S, Yalcinkaya F, Paydas S, et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrology Dialysis Transplantation 2002; 17:2003.
  32. Akçay S, Akman B, Ozdemir H, et al. Bronchiectasis-related amyloidosis as a cause of chronic renal failure. Ren Fail 2002; 24:815.
  33. Simpson T, Elston C, Macedo P, Perrin F. Amyloidosis in cystic fibrosis. Paediatr Respir Rev 2019; 31:32.
  34. Chung WS, Lin CL, Hsu WH, Kao CH. Increased risk of lung cancer among patients with bronchiectasis: a nationwide cohort study. QJM 2016; 109:17.
  35. Chung WS, Lin CL, Lin CL, Kao CH. Bronchiectasis and the risk of cancer: a nationwide retrospective cohort study. Int J Clin Pract 2015; 69:682.
Graphic 132699 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟